期刊文献+

黄芪丹参“药对”干预肾纤维化抑制因子par-3的量效关系研究 被引量:9

Effect of paired-herb on par-3 of renal fibrosis:a dose-effect research
在线阅读 下载PDF
导出
摘要 目的探讨黄芪丹参"药对"对大鼠肾间质纤维化的保护作用及其干预肾纤维化抑制因子par-3的量效关系。方法将40只雄性SD大鼠随机分为正常组(n=8)和造模组(n=32)。造模组采用单侧输尿管梗阻(UUO)建立肾间质纤维化模型,造模后分为模型组(n=8),黄芪丹参低剂量组(n=8)、中剂量组(n=8)、高剂量组(n=8)。造模后第2天开始各组给予相应的干预措施;2周后处死大鼠,收集相应标本,检测肾功能、尿α1-微球蛋白,观察肾组织病理改变,并应用Western Blot方法检测肾组织par-3蛋白的表达情况。结果①与正常组比较,模型组及各治疗组血清Cr明显高于正常组(P<0.05);除高剂量组BUN水平无差异外,其余各组血清BUN明显高于正常组(P<0.05)。②与模型组比较,各治疗组尿α1-微球蛋白均降低(P<0.05),各治疗组间差异无统计学意义(P>0.05)。③与模型组比较,各治疗组肾脏组织病理情况均有不同程度的改善。④黄芪丹参"药对"可以促进par-3的表达,并且随用药剂量的增高表达量增加。结论黄芪丹参"药对"可通过促进par-3的表达,从而保护肾小管功能,减轻肾间质纤维化的进展,并呈一定的量效关系。 Objective To observe the protective effect of the paired-herb of Radix Astragali seu Hedysarion and Radix Salviae Miltiorrhizae on par-3, and explore its action and dose-effect relationship. Methods Forty male SD rats were randomly divided into normal group ( n = 8 ) and model group ( n -- 32 ). The rats in model group were established by unilateral ureteral obstruction (UUO) and divided into the control group (n = 8 ), small-dose paired group (n =8 ), medium-dose group ( n = 8 ), large-dose group ( n = 8 ). Two days after establishment of the model, corresponding interventions were given to each group, and then the rats were killed for samples collection. The renal function, urinary α1-microglobulin, renal pathological changes were observed, and the expression of par-3 in rental tissue was detected by Western blotting. Results ① The serum Cr value in model group and treatment groups were markedly higher than that of the normal group ( P 〈 0.05 ) ; except the high-dose group, the serum BUN was significantly higher in all model groups than normal group ( P 〈 0.05 ) ;② Compared with the model group, the concentration of cd-microglobulin in treatment group was decreased ( P 〈 0.05 ), no significant difference among all treatment groups ( P 〉 0.05 ). ③Compared with control group, the pathological changes of renal tissue were improved in all treatment groups. ④ The paired-herb of Radix Astragali seu Hedysarion and Radix Salviae Miltiorrhizae can promote the expression of par-3, and the expression increased with the increase of the dose. Conclusion The paired-herb of Radix Astragali seu Hedysarion and Radix Salviae Miltiorrhizae can protect the renal tubular function and reduce the development of renal fibrosis by promoting expression of par-3 in a dose dependent manner.
出处 《上海中医药杂志》 2013年第5期77-80,共4页 Shanghai Journal of Traditional Chinese Medicine
基金 国家自然科学基金项目(30960490) 贵州省社会攻关项目[黔科合SY字(2009)3078] 贵州省省长基金项目黔省专合字[(2010)69]
关键词 黄芪 丹参 药对 肾纤维化 par-3 Radix Astragali seu Hedysarion Radix Salviae Miltiorrhizae paired-herb renal fibrosis par-3
  • 相关文献

参考文献13

  • 1Zeisberg M, Neilson EG. Mechanisms of Tubulointerstitial Fibrosis [J].JAmSoc Nephrol,2010,21 (11) : 1819-1834.
  • 2王伟铭,陈永熙,陈楠.慢性肾脏病与肾脏纤维化和炎症[J].内科理论与实践,2007,2(6):417-419. 被引量:8
  • 3Wang X, Nie J, Zhou Q, et al. Downregulation of par-5 expression and disruption of par complex integrity by TGF-beta during the process of epithelial to mesenchymal transition in rat proximal epithelial ceils [ J ]. Biochim Biophys Acta,2008,1782 ( 1 ) :51-59.
  • 4李均,曹轶璇,王冬,周萍,阳小敏.黄芪丹参药对及其有效组分对UUO大鼠肾组织JAK/STAT信号通路的影响[J].中药材,2011,34(9):1388-1391. 被引量:22
  • 5Ooshio T, Fujita N, Yamada A, et al. Cooperative roles of par 3 and afad~n in the formation of adherens and fight junctions [ J ]. Cell Sci, 2007,120 (6) :2352-2365.
  • 6Wang Z , Li SS. Numb : A new player in EMT [ J ]. Cell Adh Migr, 2010, 4(2) :176-179.
  • 7Liu YH. New Insights into Epithelial-Mesenchymal Transition in Kidney Fibrosis[J] . J Am Soc Nephrol, 2010,21 (2): 212-222.
  • 8Iden S, WE van Riel, Sehffer R, et al. Tumor type-dependent function of the par 3 polarity protein in skin tumorigenesis [ J ]. Cancer Cell, 2012, 22(3) : 389-403.
  • 9McCaffrey LM, Montalbano J, Mihai C, et al. Loss of the par 3 polarity protein promotes breast tumorigenesis and metastasis [ J ]. Cancer cell , 2012, 22(5): 601-614.
  • 10Simons M, Hartleben B, Huber TB. Podocyte polarity signaling [ J ]. Curt Opin Nephrol Hypertens, 2009, 18 (4) : 324-330.

二级参考文献63

共引文献96

同被引文献218

引证文献9

二级引证文献60

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部